Robert Kieszko

Lublin, LU, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Immune-Related Adverse Events of Checkpoint Inhibitors and Human Leukocyte Antigen System: A Review.

Immune-Related Adverse Events of Checkpoint Inhibitors and Human Leukocyte Antigen System: A Review.

Journal: ImmunoTargets and therapy

Published: June 20, 2025

MET and SLFN11 as a Players in the SCLC Molecular Subtyping Game.

MET and SLFN11 as a Players in the SCLC Molecular Subtyping Game.

Journal: International journal of molecular sciences

Published: May 07, 2025

Gut microbial predictors of first-line immunotherapy efficacy in advanced NSCLC patients.

Gut microbial predictors of first-line immunotherapy efficacy in advanced NSCLC patients.

Journal: Scientific reports

Published: May 16, 2024

Exploring immunotherapy efficacy in non-small cell lung cancer patients with BRAF mutations: a case series and literature review.

Exploring immunotherapy efficacy in non-small cell lung cancer patients with BRAF mutations: a case series and literature review.

Journal: Translational lung cancer research

Published: March 17, 2024

Gut resistome of NSCLC patients treated with immunotherapy.

Gut resistome of NSCLC patients treated with immunotherapy.

Journal: Frontiers in genetics

Published: January 30, 2024

Genetic and geographic influence on phenotypic variation in European sarcoidosis patients.

Genetic and geographic influence on phenotypic variation in European sarcoidosis patients.

Journal: Frontiers in medicine

Published: May 11, 2023

Efficacy of Dabrafenib and Trametinib in a Patient with Squamous-Cell Carcinoma, with Mutation p.D594G in BRAF and p.R461* in NF1 Genes-A Case Report with Literature Review.

Efficacy of Dabrafenib and Trametinib in a Patient with Squamous-Cell Carcinoma, with Mutation p.D594G in BRAF and p.R461* in NF1 Genes-A Case Report with Literature Review.

Journal: International journal of molecular sciences

Published: December 02, 2022

Attempting to Identify Bacterial Allies in Immunotherapy of NSCLC Patients.

Attempting to Identify Bacterial Allies in Immunotherapy of NSCLC Patients.

Journal: Cancers

Published: November 16, 2022

Presence of Akkermansiaceae in gut microbiome and immunotherapy effectiveness in patients with advanced non-small cell lung cancer.

Presence of Akkermansiaceae in gut microbiome and immunotherapy effectiveness in patients with advanced non-small cell lung cancer.

Journal: AMB Express

Published: March 28, 2022

The efficacy of T790M mutation testing in liquid biopsy-Real clinic data.

The efficacy of T790M mutation testing in liquid biopsy-Real clinic data.

Journal: PloS one

Published: October 07, 2021

Observational cross-sectional study of 5279 bronchoscopy results for the practical effectiveness of various biopsy techniques in the diagnosis of lung diseases with particular emphasis on lung cancer.

Observational cross-sectional study of 5279 bronchoscopy results for the practical effectiveness of various biopsy techniques in the diagnosis of lung diseases with particular emphasis on lung cancer.

Journal: BMJ open

Published: August 10, 2021

Crizotinib efficacy in advanced non-squamous NSCLC patients with ALK or ROS1 rearrangement.

Crizotinib efficacy in advanced non-squamous NSCLC patients with ALK or ROS1 rearrangement.

Journal: Scientific reports

Published: May 30, 2021

Showing 1-12 of 20

Last Updated: 09/26/2026